Podcast Episodes
Back to SearchThe future of CAR-T therapy in lymphoma, addressing the risk of secondary malignancy & the optimal sequencing of these agents with bispecific antibodies
Episode 246
Immunotherapeutic approaches, including CAR T-cells and bispecific antibodies, have become well-established in later lines of non-Hodgkin lymphoma (N…
2 years, 4 months ago
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
The 17th International Workshop on Multiple Myeloma (iwMyeloma 2024) was held recently in Miami, FL, and brought together experts from around the wor…
2 years, 4 months ago
iwMyeloma 2024 Session I: approaching bone disease, clinical trial updates & the value of MRD as an endpoint in trials
Episode 245
The 17th International Workshop on Multiple Myeloma (iwMyeloma 2024) was held recently in Miami, FL, and brought together experts from around the wor…
2 years, 4 months ago
Managing anemia in MF, key emerging trials in the UK, and approaching young patients with MPNs
Myelofibrosis (MF) is a hematologic malignancy that causes progressive bone marrow fibrosis and presents with other clinical manifestations, includin…
2 years, 5 months ago
Managing anemia in MF, key emerging trials in the UK, and approaching young patients with MPNs
Episode 244
Myelofibrosis (MF) is a hematologic malignancy that causes progressive bone marrow fibrosis and presents with other clinical manifestations, includin…
2 years, 5 months ago
Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome
Graft-versus-host disease (GvHD) is a common complication following allogeneic stem cell transplantation (alloSCT), which is typically classified as …
2 years, 5 months ago
Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome
Episode 243
Graft-versus-host disease (GvHD) is a common complication following allogeneic stem cell transplantation (alloSCT), which is typically classified as …
2 years, 5 months ago
The importance of cardio-oncology: awareness around the ESC 2022 guidelines & the value of building MDTs
In recent years, there has been great emphasis placed on the importance of cardio-oncology, with both cardiologists and hematologists highlighting th…
2 years, 5 months ago
The importance of cardio-oncology: awareness around the ESC 2022 guidelines & the value of building MDTs
Episode 242
In recent years, there has been great emphasis placed on the importance of cardio-oncology, with both cardiologists and hematologists highlighting th…
2 years, 5 months ago
Exploring the possibility of early interception in smoldering myeloma: novel agents, challenges & advances in risk stratification
Smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS) are two well-known precursor conditions to multiple m…
2 years, 6 months ago